- $100.75m
- $34.13m
- $616.56m
- 59
- 89
- 13
- 54
Annual income statement for DocGo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 94.1 | 319 | 441 | 624 | 617 |
| Cost of Revenue | |||||
| Gross Profit | 31.3 | 110 | 155 | 195 | 214 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 109 | 303 | 420 | 609 | 596 |
| Operating Profit | -14.8 | 15.5 | 20.5 | 15.1 | 20.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -14.6 | 19.8 | 22.8 | 16.3 | 27.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -14.8 | 19.2 | 30.7 | 10 | 13.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -14.4 | 23.7 | 34.6 | 6.86 | 20 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -14.4 | 23.7 | 34.6 | 6.86 | 20 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.246 | 0.249 | 0.354 | 0.071 | 0.219 |